Bernstein Reaffirms Their Buy Rating on Astellas Pharma (ALPMF)
Jefferies Adjusts Astellas Pharma's Price Target to 1,850 Yen From 1,700 Yen, Keeps at Hold
Bernstein Releases a Buy Rating on Astellas Pharma (ALPMF)
Buy Rating Affirmed: Astellas Pharma's Growth Soars With Padcev's Market Triumph and Upward Financial Revisions
Analysts Have Conflicting Sentiments on These Healthcare Companies: Astellas Pharma (OtherALPMF) and Verona Pharma (VRNA)
Jefferies Downgrades Astellas Pharma (ALPMF) to a Hold
Jefferies Downgrades Astellas Pharma to Hold From Buy, Adjusts Price Target to 1,700 Yen From 2,100 Yen
Analysts' Top Healthcare Picks: Astellas Pharma (ALPMF), American Well (AMWL)
Jefferies Adjusts Astellas Pharma's Price Target to 2,200 Yen From 2,400 Yen, Keeps at Buy
Jefferies Upgrades Astellas Pharma to Buy From Hold, Keeps Price Target at 2,400 Yen
Jefferies Adjusts Astellas Pharma's Price Target to 2,400 Yen From 2,300 Yen, Keeps at Buy
No Data
No Data